Cited by — Using CRISPR-X for Optimization of Antibodies Towards A30P α-synuclein Oligomers in Immunotherapy of Parkinson’s Disease | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Using CRISPR-X for Optimization of Antibodies Towards A30P α-synuclein Oligomers in Immunotherapy of Parkinson’s Disease.
No admitted local citation edges point to this work yet.
